Claritas Genomics
2013
FOUNDED
M&A
STATUS
21-30
EMPLOYEES
M&A
LATEST DEAL TYPE
Description
Operator of a genetic diagnostic laboratory to provide testing services for diagnosis of pediatric disorders. The company's laboratory offers a full range of services that take the guesswork out of selecting molecular tests and support clinicians as they navigate the increasingly complex landscape of genetic diagnostics. Its interpretive services are based on up to date and reliable findings and the reports are designed to clearly communicate complex genetic information to guide medical treatment.
Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Acquirer
Primary Office
- 99 Erie Street
- Cambridge, MA 02139
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Claritas Genomics’s full profile, request a free trial.
Claritas Genomics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 09-Feb-2018 | Completed | Out of Business | |||
| 4. Out of Business | 19-Jan-2018 | 000.00 | Completed | Out of Business | ||
| 3. Early Stage VC (Series B) | 26-Jan-2015 | 0000 | 000.00 | 0000 | Completed | Generating Revenue |
| 2. Early Stage VC (Series A2) | 18-Oct-2013 | $5M | $23.5M | 000.00 | Completed | Generating Revenue |
| 1. Early Stage VC (Series A1) | 04-Feb-2013 | $18.5M | $18.5M | 000.00 | Completed | Generating Revenue |
Claritas Genomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Series A2 | 0,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00.000 | |
| Series A1 | 18,525,000 | $0.010000 | $1 | $2 | 2x | $1 | 42.93% |
Claritas Genomics Competitors (19)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Inivata | Venture Capital-Backed | Cambridge, United Kingdom | 00000 | 00000000000 | 00000 | |
| 0000000 | Venture Capital-Backed | Mountain View, CA | 000 | 00000 | 00000000000 | 00000 |
| 0000000 00000000 | Venture Capital-Backed | San Diego, CA | 000 | 00000 | 00000000000 | 00000 |
| 00000000 | Venture Capital-Backed | Vancouver, Canada | 00 | 000.00 | 0000000000 0 | 000.00 |
| 00000 00000000 | Private Equity-Backed | Aliso Viejo, CA | 000 | 00000 | 000000&0 | 00000 |
Claritas Genomics Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Boston Children's Hospital | Corporation | Majority | 000 0000 | 000000 0 | ||
| Cerner | Corporation | Minority | 000 0000 | 000000 0 | ||
| Cincinnati Children's Hospital Medical Center | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Invitrogen | Corporation | Minority | 000 0000 | 000000 0 | ||
| WuXi NextCODE | Other | Minority | 000 0000 | 000000 0 |
Claritas Genomics Executive Team (14)
9 Former Executives
You’re viewing 5 of 14 executives. Get the full list »